Presented by
Management Forum
An Introduction to Signal Detection In-house Training
This course provides a foundation in the critical role of signal detection in ensuring the safety and efficacy of medicines.
- Format: Live online
- CPD: 1.5 hours for your records
- Certificate of completion
Part of Molecule to Medicine series:
Are you seeking an understanding of the steps that turn scientific innovations into therapeutic products? This exciting series provides a concise overview of the drug development process, from early-stage research through to the creation of medicines. Participants will learn about key topics such as molecule discovery, preclinical testing, clinical trials, and the regulatory processes involved in bringing a medicine to market.
Overview
Attending this course will help you build a strong foundation in pharmacovigilance, enhance your analytical skills, understand regulatory decision-making, stay current with advanced detection techniques, and contribute to improving patient safety. By the end of the course, you’ll understand the vital role signal detection plays in the lifecycle of medicines, from molecule to medicine!
This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.
Benefits of attending
- Gain essential knowledge of signal detection principles and practices in pharmacovigilance
- Learn how to identify, evaluate, and interpret signals from diverse data sources
- Explore how signal detection informs benefit/risk assessments and regulatory decision-making
- Develop an understanding of advanced detection techniques like data mining and disproportionality analysis
- Equip yourself to play a key role in safeguarding public health by detecting and acting on potential safety signals
Who should attend?
All clinical, pharmacovigilance and regulatory affairs personnel new to signal detection, or in need of a refresher, would benefit from this course.
Graeme Ladds
PharSafer Associates Ltd
Graeme Ladds, Director of PharSafer, has over 30 years’ experience working in the pharmaceutical industry. Having started his career at Ashbourne Pharmaceuticals in 1989 as Head of Drug Safety & Medical Information, he went on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals. He then set up his consultancy and specialist CRO company, PharSafer Associates Ltd, where he has been involved in establishing pharmacovigilance in companies, performing audits across Europe and the USA, SOP writing, acting as QP for companies, and helping with regulatory inspections.
Romania
- SC MENECA SRL
